ÂÜÀòÂÒÂ×

Bradley Bloom has an extensive work experience spanning over several companies and roles. Bradley is currently serving as the Vice President of Clinical Development at Celldex Therapeutics starting from November 2022. Prior to this, they held the position of Executive Director and Therapeutic Area Head of Immunology and Inflammation at Mitsubishi Tanabe Pharma Development America from November 2020 to November 2022.

From July 2019 to November 2020, Bradley worked as an Executive Medical Director at Corbus Pharmaceuticals, and prior to that, as a Senior Medical Director from June 2018 to June 2019. Before joining Corbus Pharmaceuticals, they held the position of Senior Medical Director at Covance from September 2013 to June 2018.

Bradley has also worked as a Medical Director at Vertex Pharmaceuticals from June 2012 to September 2013, as a Medical Director at Shire HGT from August 2009 to June 2012, and as the Director of Clinical Research at Pfizer from August 2002 to June 2009. Bradley specialized in designing, running, overseeing, and interpreting clinical trials in rheumatologic diseases during their tenure at Pfizer.

Prior to their industry experience, Bradley served as the Co-Director of Pediatric Rheumatology and Assistant Professor of Pediatrics at Brown U. Medical School at Rhode Island Hospital from July 1995 to August 2002. In this role, they developed and ran a clinical program in pediatric rheumatology and led a research program specializing in translational research related to markers of endothelial activation in juvenile arthritis. Bradley also taught medical students, residents, fellows, and colleagues during their time at Rhode Island Hospital.

Overall, Bradley's work experience demonstrates their expertise in clinical development, immunology and inflammation, medical direction, and clinical research, showcasing their extensive knowledge and skills in the pharmaceutical and medical sectors.

Bradley Bloom pursued their education from 1985 to 1989 at Northwestern University - The Feinberg School of Medicine. During this period, they completed a degree in MD. Further details regarding their field of study are not provided.